2 ms·
I bet you could count on two hands the number of U.S. patients who will pay for this drug directly, and they could all afford it 10x over. Yet Gilead will still
by twoodfin 13y ago
I bet you could count on two hands the number of U.S. patients who will pay for this drug directly, and they could all afford it 10x over. Yet Gilead will still sell plenty of it here.
So I'm not sure what you're saying about the U.S. "model".
- kseistrup 13y agoI'm saying about the US model for medicare that you either have to pay for your treatment or you have to have a health insurance that will pay for you. This is in contrast to e.g. the Scandinavian countries where you get treated whether you have an insurance or not, no matter what your income level is. Those are two “models” of paying for your medicare, and I'm sure there are even other ways.